Literature DB >> 2949739

Degradation of atrial natriuretic factor in the rat.

K K Murthy, G Thibault, R Garcia, J Gutkowska, J Genest, M Cantin.   

Abstract

The biologically active circulating form of atrial natriuretic factor (ANF) in the rat is the 28-amino-acid peptide ANF-(Ser-99-Tyr-126). Degradation of this peptide in vivo as well as in vitro, in whole blood, in plasma and by the isolated mesenteric artery was investigated. Studies in vivo in the rat demonstrated that the elimination and degradation of ANF was extremely fast: within 3 min more than 95% of the injected immunoreactive material was eliminated from circulation. The production of a short C-terminal peptide was detected on injection of 125I-ANF-(Ser-99-Tyr-126) into the rat. This peptide increased proportionately with incubation time. Experiments in vitro in the presence of whole blood or plasma did not cause any major destruction of ANF even after incubation for 60 min. After this prolonged incubation in plasma, ANF-(Ser-99-Tyr-126) was partially converted into ANF-(Ser-103-Tyr-126), a less potent peptide. Isolated mesenteric-artery preparation appeared to degrade ANF in a manner very similar to the system in vivo. These results suggest that degradation of ANF may occur either after internalization in the vascular cells or by a membrane-bound enzyme in the vasculature.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2949739      PMCID: PMC1147439          DOI: 10.1042/bj2400461

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  33 in total

1.  THE EFFECT OF SYMPATHETIC NERVE STIMULATION OF VASOCONSTRICTOR RESPONSES IN PERFUSED MESENTERIC BLOOD VESSELS OF THE RAT.

Authors:  D D MCGREGOR
Journal:  J Physiol       Date:  1965-03       Impact factor: 5.182

2.  Natriuretic activity of extracts obtained from hearts of different species and from various rat tissues.

Authors:  A J de Bold; T A Salerno
Journal:  Can J Physiol Pharmacol       Date:  1983-02       Impact factor: 2.273

3.  Cardiovascular effects of atrial extracts in anesthetized rats.

Authors:  U Ackermann; T G Irizawa; S Milojevic; H Sonnenberg
Journal:  Can J Physiol Pharmacol       Date:  1984-07       Impact factor: 2.273

4.  Primary structure of a high Mr form of rat atrial natriuretic factor.

Authors:  G Thibault; R Garcia; M Cantin; J Genest; C Lazure; N G Seidah; M Chrétien
Journal:  FEBS Lett       Date:  1984-02-27       Impact factor: 4.124

5.  Bioactive cardiac substances: potent vasorelaxant activity in mammalian atria.

Authors:  M G Currie; D M Geller; B R Cole; J G Boylan; W YuSheng; S W Holmberg; P Needleman
Journal:  Science       Date:  1983-07-01       Impact factor: 47.728

6.  Direct radioimmunoassay of atrial natriuretic factor.

Authors:  J Gutkowska; G Thibault; P Januszewicz; M Cantin; J Genest
Journal:  Biochem Biophys Res Commun       Date:  1984-07-31       Impact factor: 3.575

7.  Natriuretic activity of human and monkey atria.

Authors:  M N Nemeh; J P Gilmore
Journal:  Circ Res       Date:  1983-09       Impact factor: 17.367

8.  Effect of a purified atrial natriuretic factor on rat and rabbit vascular strips and vascular beds.

Authors:  R Garcia; G Thibault; M Cantin; J Genest
Journal:  Am J Physiol       Date:  1984-07

9.  Rat atrial natriuretic factor. Purification and vasorelaxant activity.

Authors:  R T Grammer; H Fukumi; T Inagami; K S Misono
Journal:  Biochem Biophys Res Commun       Date:  1983-10-31       Impact factor: 3.575

10.  Tissue fractionation studies on the relationship between an atrial natriuretic factor and specific atrial granules.

Authors:  A J de Bold
Journal:  Can J Physiol Pharmacol       Date:  1982-03       Impact factor: 2.273

View more
  7 in total

1.  Contribution of blood and systemic circulation to the processing of pro-(atrial natriuretic factor).

Authors:  K K Murthy; G Thibault; M Cantin
Journal:  Biochem J       Date:  1988-03-15       Impact factor: 3.857

2.  Clearance and early hydrolysis of atrial natriuretic factor in vivo. Structural analysis of cleavage sites and design of an analogue that inhibits hormone cleavage.

Authors:  C L Condra; E A Leidy; P Bunting; C D Colton; R F Nutt; M Rosenblatt; J W Jacobs
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

3.  The hydrolysis of alpha-human atrial natriuretic peptide by pig kidney microvillar membranes is initiated by endopeptidase-24.11.

Authors:  S L Stephenson; A J Kenny
Journal:  Biochem J       Date:  1987-04-01       Impact factor: 3.857

4.  Rapid receptor-mediated catabolism of 125I-atrial natriuretic factor by vascular endothelial cells.

Authors:  G R Johnson; L Arik; B J Pitts; C J Foster
Journal:  Biochem J       Date:  1990-06-15       Impact factor: 3.857

5.  In vivo measurement of ANP overall turnover and identification of its main metabolic pathways under steady state conditions in humans.

Authors:  A Clerico; G Iervasi; S Berti; A Pilo; F Vitek; S Salvadori; M Marastoni; C Manfredi; M G Del Chicca; M R Iascone
Journal:  J Endocrinol Invest       Date:  1995-03       Impact factor: 4.256

6.  Hydrolysis of alpha-human atrial natriuretic peptide in vitro by human kidney membranes and purified endopeptidase-24.11. Evidence for a novel cleavage site.

Authors:  Y Vanneste; A Michel; R Dimaline; T Najdovski; M Deschodt-Lanckman
Journal:  Biochem J       Date:  1988-09-01       Impact factor: 3.857

7.  Influence of atrial natriuretic peptide, brain natriuretic peptide and urodilatin on the histamine-induced bronchoconstriction in the conscious guinea pig.

Authors:  M Hermel
Journal:  Inflammopharmacology       Date:  1998       Impact factor: 5.093

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.